First add-on perampanel for focal-onset seizures: An open-label, prospective study (vol 141, pg 132, 2020)

被引:0
|
作者
Kim, J. H.
Kim, D. W.
Lee, S. K.
Seo, D. W.
Lee, J. W.
Park, H. J.
Lee, S. A.
机构
来源
ACTA NEUROLOGICA SCANDINAVICA | 2020年 / 142卷 / 04期
关键词
D O I
10.1111/ane.13309
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:396 / 397
页数:2
相关论文
共 50 条
  • [21] Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy
    Farrell, K
    Connolly, MB
    Munn, R
    Peng, SM
    MacWilliam, LM
    PEDIATRIC NEUROLOGY, 1997, 16 (03) : 201 - 205
  • [22] Levetiracetam as an add-on therapy for adult epilepsy patients: An open-label, prospective, observational study
    Aktekin, B.
    Ekmekci, Usta B.
    Apaydin, Dogan E.
    Senol, Y.
    EPILEPSIA, 2007, 48 : 111 - 111
  • [23] Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342)
    Yamamoto, Takamichi
    Lim, Sung Chul
    Ninomiya, Hirotomo
    Kubota, Yuichi
    Shin, Won Chul
    Kim, Dong Wook
    Shin, Dong Jin
    Iida, Koji
    Ochiai, Taku
    Matsunaga, Risa
    Hiramatsu, Hidetaka
    Kim, Ji Hyun
    EPILEPSY RESEARCH, 2025, 210
  • [24] LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting
    Munoz-Lopetegi, Amaia
    Javier Lopez-Gonzalez, Francisco
    Rodriguez-Osorio, Xiana
    Pato Pato, Antonio
    Bellas Lamas, Paula
    Abella-Corral, Javier
    Castro Vilanova, Maria Dolores
    Jose Garea, Maria
    Gil Lopez, Juan Antonio
    Ruiz-Martinez, Javier
    Jose Poza, Juan
    EPILEPSY RESEARCH, 2018, 145 : 51 - 54
  • [25] ELEVATE Study 410: analysis of time to first seizure with perampanel as monotherapy or first adjunctive therapy in patients with focal-onset seizures or generalised tonic-clonic seizures
    Klein, P.
    Samad, O.
    Ngo, L. Y.
    Kumar, D.
    Malhotra, M.
    EPILEPSIA, 2023, 64 : 295 - 296
  • [26] Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study
    Appleton, R
    Fichtner, K
    LaMoreaux, L
    Alexander, J
    Maton, S
    Murray, G
    Garofalo, E
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (04): : 269 - 273
  • [27] Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
    Jeffrey L Berlant
    BMC Psychiatry, 4
  • [29] A phase IV, prospective, post-approval study of adjunctive perampanel in indian patients aged ≥12 Years with focal-onset seizures: Study 508
    Rohatgi, Anshu
    Ravat, Sangeeta
    Patil, Balaji
    Dash, Amitabh
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 48 - 48
  • [30] Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)
    Abril Jaramillo, Javier
    Estevez Maria, Jose Carlos
    Giron Ubeda, Juan Miguel
    Vega Lopez, Oscar
    Calzado Rivas, Maria Elena
    Perez Diaz, Hernando
    Garcia Martin, Guillermina
    Vila Herrero, Elena
    Chamorro-Munoz, M.
    Vazquez, F.
    De la Fuente, C.
    Redondo, L.
    Pelaez, N.
    Santagueda, Patricia
    Rodriguez Uranga, Juan Jesus
    EPILEPSY & BEHAVIOR, 2020, 102